J Clin Neurol.  2019 Jul;15(3):404-406. 10.3988/jcn.2019.15.3.404.

Recurrent Guillain-Barré Syndrome with Anti-GT1a and Anti-GQ1b Ganglioside Antibodies

• Hwang J
• Kwon YJ
• Kim JK
• Kim NJ
• Baek SH

• KMID: 2451129
• DOI: http://doi.org/10.3988/jcn.2019.15.3.404

Abstract

No abstract available.

MeSH Terms

Antibodies*
Guillain-Barre Syndrome*
Antibodies

Reference

1. Grand'Maison F, Feasby TE, Hahn AF, Koopman WJ. Recurrent Guillain-Barré syndrome. Clinical and laboratory features. Brain. 1992; 115:1093–1106. PMID: 1393505.

2. Kim JK, Bae JS, Kim DS, Kusunoki S, Kim JE, Kim JS, et al. Prevalence of anti-ganglioside antibodies and their clinical correlates with Guillain-Barré syndrome in Korea: a nationwide multicenter study. J Clin Neurol. 2014; 10:94–100. PMID: 24829594.

3. Pyun SY, Jeong JH, Bae JS. Recurrent Guillain-Barré syndrome presenting stereotypic manifestations, positive antiganglioside antibodies, and rapid recovery. Clin Neurol Neurosurg. 2015; 139:230–233. PMID: 26519894.

4. Ito H, Hatanaka Y, Fukami Y, Harada Y, Kobayashi R, Okada H, et al. Anti-ganglioside complex antibody profiles in a recurrent complicated case of GQ1b-seronegative Miller Fisher syndrome and Bickerstaff brainstem encephalitis: a case report. BMC Neurol. 2018; 18:72. PMID: 29792178.

5. Yalinay Dikmen P, Emre Oge A. Recurrent GBS with GD1a anti-ganglioside antibodies. J Peripher Nerv Syst. 2012; 17:135–137. PMID: 22462676.